Mubadala Bio

NEWS DESK

Mubadala Bio and Marcyrl Group Sign a Strategic Partnership to Localize Women’s Health, Fertility and Respiratory Therapies in the UAE

News Desk 22/10/2026

Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localize a broad portfolio of women’s health, fertility and respiratory products in the UAE. Dr. Essam Mohamed, Group Chief Executive Officer of Mubadala Bio, and Dr. George Saad, Chief

NEWS DESK

Lilly and Mubadala Bio announce landmark agreement to advance pharmaceutical contract manufacturing in Abu Dhabi

News Desk 21/10/2026

Eli Lilly and Company (Lilly) and Mubadala Bio today announced a strategic collaboration to advance the localized packaging and logistics  of Lilly’s GLP-1 medicines in Abu Dhabi, marking an important step in a shared commitment to advancing the Emirate’s growing life sciences ecosystem. The partnership was announced at the Abu Dhabi Future Health Summit (ADFHS) […]

NEWS DESK

Mubadala Bio Announces Executive Leadership Updates

PR News Desk 23/09/2025

Mubadala Bio, a life sciences company committed to advancing better health outcomes for the UAE and beyond, has announced executive leadership updates. These appointments highlight the company’s focus on operational excellence, strategic growth, and innovation. The announcement reflects Mubadala Bio’s dedication to advancing the life sciences industry, enhancing drug

NEWS DESK

Mubadala Launches its Latest National Champion – “Mubadala Bio” to Transform Life Sciences in the UAE and Beyond

PR News Desk 19/05/2025

 Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, today announced the launch of Mubadala Bio, a life sciences company committed to strengthening the life sciences sector in the UAE and advancing better health outcomes for the UAE and the world. The launch of this National Champion represents a strategic step that reflects Mubadala’s